Cambridge Cognition is a technology company that has developed a suite of computer-based cognitive assessments to improve the understanding, diagnosis and treatment of neurological and psychological diseases. Demand for these products is increasing in the fields of drug development, academic research and occupational health. The company’s integrated product offering covers every stage of drug development and it has invested in infrastructure to support an accelerated growth strategy. Despite this, the shares are rated at the lower end of an international peer group, which suggests that there is further upside potential.
13 Oct 2016
Mindset for growth
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Mindset for growth
Cambridge Cognition Holdings Plc (COG:LON) | 52.0 0 0.0% | Mkt Cap: 18.3m
- Published:
13 Oct 2016 -
Author:
Martin Hall -
Pages:
36
Cambridge Cognition is a technology company that has developed a suite of computer-based cognitive assessments to improve the understanding, diagnosis and treatment of neurological and psychological diseases. Demand for these products is increasing in the fields of drug development, academic research and occupational health. The company’s integrated product offering covers every stage of drug development and it has invested in infrastructure to support an accelerated growth strategy. Despite this, the shares are rated at the lower end of an international peer group, which suggests that there is further upside potential.